reaction antibody monoclonal hypersensitivity severe history mab components infusion allergy 
pembrolizumab nivolumab hypersensitivity prior dose treatment received therapy known mk 
mannitol hypersensitivity boron bortezomib azacitidine known suspected allergy velcade history 
talazoparib components hypersensitivity known capsule suspected bmn treatment previous prior 
reaction allergic history prior hypersensitivity involved known severe protocol drug 
component hypersensitivity known formulation allergy bevacizumab study reaction history drug 
components allergy history drug study known hypersensitivity nivolumab treatment reaction 
fentanyl allergy history propofol opioids patches transdermal tolerant lidocaine midazolam 
formulation components allergy hypersensitivity identified previously study subject treatment known 
formulations allergy components hypersensitivity identified previously component study known cobimetinib 
